Trial intelligence / Profile preview

Arnica for Acute Musculoskeletal Pain in Children

NCT05283434Phase 3Unknown

Sponsor
Children's Minnesota
Start
Jul 2021
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of arnica in Musculoskeletal pain, acute pain, sponsored by Children's Minnesota. Status: unknown.

02

Drugs

arnica
03

Conditions

Musculoskeletal painacute pain

Beyond the preview

Go deeper on NCT05283434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05283434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call